QR Kod

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy

IntroductionDecline in kidney function due to renal fibrosis is a potential side effect in patients with neuroendocrine neoplasm (NEN) undergoing Peptide Receptor Radionuclide Therapy (PRRT). We aimed to investigate the potential of circulating fibrosis markers reflecting formation and degradation o...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Tobias Stemann Lau, Lars Bossen, Daniel Guldager Kring Rasmussen, Federica Genovese, Morten Karsdal, Anne Kirstine Arveschoug, Henning Grønbæk, Gitte Dam
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2025-06-01
Seri Bilgileri:Frontiers in Endocrinology
Konular:
PRRT
fibrosis markers
biomarkers
neuroendocrine neoplasms
neuroendocrine tumors
kidney fibrosis
Online Erişim:https://www.frontiersin.org/articles/10.3389/fendo.2025.1495369/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller